StrataGraft® Skin Tissue Expanded Access at Specific Study Sites ( StrataCAT )
Clinical trial NCT04123548 · COMPLETED
Trial details
- NCT number
- NCT04123548
- Sponsor
- Stratatech, a Mallinckrodt Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2022-01-26
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.